Patient Square Capital to acquire NanoString Technologies for $220m.

Patient Square Capital, a healthcare investment firm, agreed to acquire NanoString Technologies, a provider of life science tools for discovery and translational research for $220m “This agreement with Patient Square provides continuity for our scientific customers and employees, and represents an important step in our financial restructuring. We believe that Patient Square is committed to continuing NanoString’s mission to Map the Universe of Biology and is prepared to invest in our market-leading product roadmap,” Brad Gray, NanoString Technologies President & CEO.